Vienna Insurance Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,671
Closed -$867K 27
2025
Q2
$867K Sell
4,671
-1,796
-28% -$334K 0.55% 45
2025
Q1
$1.35M Buy
6,467
+178
+3% +$34.6K 0.74% 25
2024
Q4
$1.12M Sell
6,289
-1,219
-16% -$224K 0.65% 58
2024
Q3
$1.48M Sell
7,508
-229
-3% -$42.7K 0.63% 46
2024
Q2
$1.33M Buy
7,737
+35
+0.5% +$5.8K 0.52% 51
2024
Q1
$1.4M Sell
7,702
-201
-3% -$34.6K 0.55% 54
2023
Q4
$1.22M Sell
7,903
-4,624
-37% -$674K 0.56% 68
2023
Q3
$1.87M Buy
12,527
+3,939
+46% +$578K 0.83% 26
2023
Q2
$1.16M Buy
8,588
+3,475
+68% +$510K 0.54% 84
2023
Q1
$815K Buy
+5,113
New +$782K 0.48% 30
2020
Q1
Sell
-18,979
Closed -$1.68M 13
2019
Q4
$1.68M Sell
18,979
-10,781
-36% -$895K 1.56% 6
2019
Q3
$2.25M Buy
29,760
+8,647
+41% +$593K 1.91% 5
2019
Q2
$1.54M Buy
21,113
+2,267
+12% +$178K 1.57% 48
2019
Q1
$1.52M Sell
18,846
-7,394
-28% -$605K 1.59% 50
2018
Q4
$2.42M Buy
26,240
+17,206
+190% +$1.51M 1.86% 2
2018
Q3
$854K Buy
9,034
+417
+5% +$39.5K 0.57% 47
2018
Q2
$798K Buy
8,617
+373
+5% +$36.4K 0.55% 43
2018
Q1
$780K Sell
8,244
-952
-10% -$105K 0.52% 54
2017
Q4
$889K Buy
+9,196
New +$867K 0.53% 34

Other funds holding ABBV

Vienna Insurance Group's ABBV Position: Q3 2025 in Review

Vienna Insurance Group sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 4,671 shares — an estimated $867K sold.

Vienna Insurance Group first reported a position in ABBV in Q4 2017 and held it in 19 quarters. The position peaked at $2.42M in Q4 2018. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Vienna Insurance Group reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
  • Vienna Insurance Group sold 4,671 AbbVie shares in Q3 2025, an estimated $867K.
  • Vienna Insurance Group first reported a position in AbbVie in Q4 2017 and held it in 19 quarters.
  • Vienna Insurance Group's AbbVie position peaked at $2.42M in Q4 2018.
  • 3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Vienna Insurance Group's 13F filing for Q3 2025, filed 3 Nov 2025.